{{Rsnum
|rsid=12303914
|Gene=KLRD1
|Chromosome=12
|position=10318451
|Orientation=plus
|GMAF=0.3935
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=KLRD1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 11.3 | 48.4 | 40.3
| HCB | 2.2 | 31.1 | 66.7
| JPT | 6.8 | 34.1 | 59.1
| YRI | 50.8 | 34.4 | 14.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.2 | 31.1 | 66.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=A
  |Pval=6E-6
  |OR=20.39
  |ORtxt=[11.51-29.27] mg/dL increase
  |OA=1
}}